Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Tanzi

Showing results (551-560 of 579) with videos related to

Pageof 58
Sort By:
Nature Medicine|June 24, 2020
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's diseaseSimon Dujardin, Caitlin Commins, Aurelien Lathuiliere, et al.
Neurology|July 25, 2024
Brain Care Score and Neuroimaging Markers of Brain Health in Asymptomatic Middle-Age PersonsCyprien A Rivier, Sanjula Singh, Jasper Senff, et al.
Science (New York, N.Y.)|November 8, 2008
GENETICS. The Human Variome ProjectRichard G H Cotton, Arleen D Auerbach, Myles Axton, et al.
Science Translational Medicine|July 30, 2025
Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer's diseaseRicardo D'Oliveira Albanus, Gina M Finan, Logan Brase, et al.
BMC Public Health|November 29, 2025
U.S. public perceptions on whether risk of dementia and stroke can be modified through maintaining or changing lifestyleJasper R Senff, Mark Jun Shah-Ostrowski, Reinier W P Tack, et al.
Nature|June 29, 1995
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's diseaseR Sherrington, E I Rogaev, Y Liang, et al.
Nature Immunology|September 4, 2023
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
Science Translational Medicine|May 18, 2012
Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse modelLee E Goldstein, Andrew M Fisher, Chad A Tagge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Pageof 58

Showing results (551-560 of 579) with videos related to

Sort By:
Pageof 58
Nature Medicine|June 24, 2020
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's diseaseSimon Dujardin, Caitlin Commins, Aurelien Lathuiliere, et al.
Neurology|July 25, 2024
Brain Care Score and Neuroimaging Markers of Brain Health in Asymptomatic Middle-Age PersonsCyprien A Rivier, Sanjula Singh, Jasper Senff, et al.
Science (New York, N.Y.)|November 8, 2008
GENETICS. The Human Variome ProjectRichard G H Cotton, Arleen D Auerbach, Myles Axton, et al.
Science Translational Medicine|July 30, 2025
Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer's diseaseRicardo D'Oliveira Albanus, Gina M Finan, Logan Brase, et al.
BMC Public Health|November 29, 2025
U.S. public perceptions on whether risk of dementia and stroke can be modified through maintaining or changing lifestyleJasper R Senff, Mark Jun Shah-Ostrowski, Reinier W P Tack, et al.
Nature|June 29, 1995
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's diseaseR Sherrington, E I Rogaev, Y Liang, et al.
Nature Immunology|September 4, 2023
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)Amy D Proal, Michael B VanElzakker, Soo Aleman, et al.
Science Translational Medicine|May 18, 2012
Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse modelLee E Goldstein, Andrew M Fisher, Chad A Tagge, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|September 24, 2024
A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsHoward H Feldman, Jeffrey L Cummings, Adam L Boxer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Pageof 58